ArticleJournal of the National Cancer Institute2018

Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.

Naris Nilubol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.